Universitätsklinikum Essen

Hospital


Location: Essen, Germany (DE) DE

ISNI: 0000000102627331

ROR: https://ror.org/02na8dn90

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Real-world management bei Patienten mit Komplettremission unter Immuncheckpoint-Inhibition bei fortgeschrittenem Melanom (2025) Reitmajer M, Livingstone E, Thoms KM, Heppt M, Meiss F, Gesierich A, Drexler K, et al. Journal article Brain acid sphingomyelinase controls addiction-related behaviours in a sex-specific way (2025) Kalinichenko L, Zoicas I, Bienia AM, Bühner C, Robinson J, Küttermeyer J, Labonte A, et al. Journal article Therapy response prediction of focal cortex stimulation based on clinical parameters: a multicentre, non-interventional study protocol (2025) Kalousios S, Hesser J, Dümpelmann M, Baumgartner C, Hamer H, Hirsch M, Imbach L, et al. Journal article xCT as a potential marker for neuroendocrine cells in high-risk prostate cancer and the relation to AL122023.1-miR-26a/30d/30e axis (2025) Wilhelm ED, Dankert JT, Wiesehöfer M, Wach S, Wagner M, Spahn M, Julio MKD, Wennemuth G Journal article Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer (2025) Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, et al. Journal article Discordance, accuracy and reproducibility study of pathologists' diagnosis of melanoma and melanocytic tumors (2025) Haggenmüller S, Wies C, Abels J, Winterstein JT, Heinlein L, Nogueira Garcia C, Utikal JS, et al. Journal article Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma. (2025) Tomsitz D, Livingstone E, Loquai C, Kaatz M, Leiter U, Schilling B, Terheyden P, et al. Journal article Needs, distress, state-of-health and quality-of-life in survivors of stage III melanoma: Results from the cross-sectional MESSAGE study (2025) Skoda EM, Jansen C, Peltz L, Schweda A, Teufel M, Livingstone E, Zimmer L, et al. Journal article Risk of moderate or severe hypoxic ischemic encephalopathy does not correlate with prenatally known risk factors (2025) Rüdiger M, Kehl S, Wiechers C, Kribs A, Pecks U, Mildenberger E, Glaser K, et al. Journal article